Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study

2020 ◽  
Vol 39 (9) ◽  
pp. 2751-2756 ◽  
Author(s):  
Patricia Richi ◽  
Oriol Alonso ◽  
María Dolores Martín ◽  
Laura González-Hombrado ◽  
Teresa Navío ◽  
...  
Keyword(s):  
Immune Response ◽  
Cohort Study ◽  
Hepatitis B ◽  
Biological Therapy ◽  
Hepatitis B Vaccine

scholarly journals Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda

Vaccine ◽  
2021 ◽  
Vol 39 (8) ◽  
pp. 1265-1271
Author(s):  
E. Seremba ◽  
P. Ocama ◽  
R. Ssekitoleko ◽  
H. Mayanja-Kizza ◽  
S.V. Adams ◽  
...  
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hepatitis B Vaccine

Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy

Vaccine ◽  
1991 ◽  
Vol 9 (10) ◽  
pp. 747-750 ◽  
Author(s):  
Giuseppe Giammanco ◽  
Salvatore Li Volti ◽  
Luisa Mauro ◽  
Giuseppe Giammanco Bilancia ◽  
Isabella Salemi ◽  
...  
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Recombinant Dna ◽  
Hepatitis B Vaccine ◽  
Simultaneous Administration

scholarly journals IMMUNOGLOBULIN (IG) LEVELS AND IMMUNE RESPONSE TO HEPATITIS B VACCINE IN CHILDREN WITH CANCER 130

1997 ◽  
Vol 41 (5) ◽  
pp. 771-771
Author(s):  
J P Panagiotou ◽  
S Polychronopoulou ◽  
S Kostaridou ◽  
K Spanou ◽  
O Moraloglou ◽  
...  
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hepatitis B Vaccine ◽  
Children With Cancer

Immune response to hepatitis B vaccine in parenteral drug abusers

Vaccine ◽  
1992 ◽  
Vol 10 (11) ◽  
pp. 798-801 ◽  
Author(s):  
J.M. Rodrigo ◽  
M.A. Serra ◽  
L. Aparisi ◽  
A. Escudero ◽  
M.S. Gilabert ◽  
...  
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hepatitis B Vaccine ◽  
Drug Abusers ◽  
Parenteral Drug

scholarly journals Antibody response to heat-inactivated hepatitis B vaccine (CLB-3mg) in hemodialysis patients and occupational risk personnel: a one year follow-up

1988 ◽  
Vol 30 (1) ◽  
pp. 11-16
Author(s):  
C. F. T. Yoshida ◽  
C. Takahashi ◽  
L. A. C. Mercadante ◽  
I. F. Camargo ◽  
H. G. Schatzmayr
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Occupational Risk ◽  
Immunization Schedule ◽  
One Year ◽  
Sample Ratio ◽  
Healthy Persons

Immune response against hepatitis B vaccine (CLB 3mg) was evaluated in 59 hemodialysis patients and 20 occupational risk personnel. Seroconversion was induced in 52.5% and 70.0% respectively. Twelve months after the first dose, 37.5% of patients and 60.0% of occupational risk personnel had detectable anti-HBs level. Antibody level was expressed in sample ratio units (SRU). Considering only the responders, in the patients group 38.7% had a low anti-HBs response (2.1-9.9 SRU) 32.3% a medium response (10-99.9 SRU) and 29.0% a high response (>100 SRU) while in occupational risk personnel these values were 14.3%, 64.3% and 21.4% respectively. The authors suggest the use of HBV vaccines with more elevated HBsAg concentration or a reinforced immunization schedule to improve the anti-HBs response not only for patients but also for healthy persons.

scholarly journals Evaluation of Immune Response to Hepatitis B Vaccine in Healthcare Workers at a Tertiary Care Hospital

2018 ◽  
Vol 36 (3) ◽  
pp. 397-400
Author(s):  
Praveena Basireddy ◽  
Surekha Avileli ◽  
Nagajyothi Beldono ◽  
Swarna Latha Gundela
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Healthcare Workers ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Hepatitis B Vaccine ◽  
Care Hospital

scholarly journals Hepatitis B vaccine - proposal for a standardized assessment of immune response

1992 ◽  
Vol 34 (2) ◽  
pp. 137-140 ◽  
Author(s):  
Maria Lucia G. Ferraz ◽  
Antonio Eduardo Silva ◽  
Marico Yamamoto ◽  
Rubens Xavier Guimaråes
Keyword(s):  
Health Care ◽  
Immune Response ◽  
Hepatitis B ◽  
Quantitative Determination ◽  
Health Care Professionals ◽  
Vaccination Programme ◽  
Quantitative Assessment ◽  
Reference Method ◽  
Hepatitis B Vaccine

The authors developed a comparative study of the various methods of assessment of immune response to Hepatitis B vaccine. Eighty-six health care professionals underwent a vaccination programme with three doses of plasma-derived vaccine against Hepatitis B (H-B-Vax, Merck, Sharp & Dohme) given intra-muscularly. Assessment of immune response was carried out three months after the end of the programme, by radioimmunoassay (RIA) and enzymeimmunoassay (EIA). The results showed that the semi-quantitative assessment of Anti-HBs antibodies by RIA or EIA was perfectly comparable to the reference method (quantitative determination of antibodies by RIA). In view of these findings, the authors suggest a standardization of assessment of immune response to the vaccine, thus permitting correct planning of booster doses and easier comparison between different studies

Sign in / Sign up

Export Citation Format

Share Document